Policy Implications of Gene Editing and Biotechnology Regulation

View Sample PDF

Author(s): Rebet Keith Jones (Capitol Technology University, USA)
Copyright: 2025
Pages: 34
Source title: Navigating Law and Policy in STM Enterprises: Ethical Governance, Regulation, and Innovation Strategy
Source Author(s)/Editor(s): Hewa Majeed Zangana (Duhok Polytechnic University, Iraq), Jamal Al-Karaki (Zayed University, UAE)and Marwan Omar (Illinois Institute of Technology, USA)
DOI: 10.4018/979-8-3373-4862-9.ch012

Keywords: Business Ethics and Law / Business Science Reference / Ethics & Law / Security & Forensics

Purchase

View Policy Implications of Gene Editing and Biotechnology Regulation on the publisher's website for pricing and purchasing information.

Abstract

Gene editing and biotechnology represent transformative advancements with profound potential to reshape medicine, agriculture, and environmental management. However, their rapid development poses significant regulatory and ethical challenges that require comprehensive policy frameworks. This chapter explores the policy implications surrounding gene editing technologies, such as CRISPR, highlighting the balance between fostering innovation and ensuring public safety, ethical standards, and equitable access. It discusses regulatory approaches adopted worldwide, the role of international cooperation, and the socio-political dynamics influencing governance. By examining current legislative landscapes and emerging best practices, the chapter aims to inform policymakers, legal scholars, and industry stakeholders about effective governance models that align with ethical imperatives and technological progress.

The IRMA Community

Research IRM

Policy Implications of Gene Editing and Biotechnology Regulation

Purchase

Abstract

Related Content

IRMA Sponsors